<?xml version="1.0" encoding="UTF-8" ?>








    
    
    
    













        
            
            
        <!-- FT CACHE --> 

<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="http://www.ft.com/FTCOM/XSL/styleRSSFeed.xsl"?><rss xmlns:java="java" xmlns:ft="http://www.ft.com/FTRSSExtensions" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><atom:link type="application/xml" rel="self" href="http://www.ft.com/rss/companies/health"/><title>FT.com - Health</title><link>http://www.ft.com/companies/health</link><ft:rsslink>http://www.ft.com/rss/companies/health</ft:rsslink><description>FT.com - Health</description><language>en</language><copyright>© Copyright The Financial Times Ltd 2009. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.</copyright><webMaster>client.support@ft.com (Client Support)</webMaster><pubDate>Fri, 20 Nov 2009 20:39:24 +0000</pubDate><lastBuildDate>Sat, 21 Nov 2009 05:14:43 +0000</lastBuildDate><category>Newspapers</category><ttl>15</ttl><image><url>http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gif</url><title>FT.com - Health</title><link>http://www.ft.com/companies/health</link></image><rating>(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))</rating><item><title>J&amp;J stays true to its diversified model</title><link>http://traxfer.ft.com/cms/s/0/d6e0a888-d606-11de-b80f-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/d6e0a888-d606-11de-b80f-00144feabdc0.html</guid><description>Johnson &amp; Johnson defends its strategy, with its three broad divisions of medical devices, consumer health and pharmaceuticals, even as the approach fails to shield it from industry pains</description><pubDate>Fri, 20 Nov 2009 20:39:24 +0000</pubDate></item><item><title>Philip Morris ordered to pay $300m to smoker</title><link>http://traxfer.ft.com/cms/s/0/94d403da-d57b-11de-81ee-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/94d403da-d57b-11de-81ee-00144feabdc0.html</guid><description>A Florida jury orders cigarette maker Philip Morris USA to pay $300m in damages to a 61-year-old ex-smoker who is wheelchair-bound by emphysema</description><pubDate>Fri, 20 Nov 2009 02:33:47 +0000</pubDate></item><item><title>Cheap does not mean cheerful, says Toys R Us</title><link>http://traxfer.ft.com/cms/s/0/0608ea72-d575-11de-81ee-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/0608ea72-d575-11de-81ee-00144feabdc0.html</guid><description>This year's hard-to-find Christmas toy in the US, the Zhu Zhu Pets robotic hamster, costs about $10. But as he flips through Toys R Us's annual catalogue at the...</description><pubDate>Fri, 20 Nov 2009 02:00:00 +0000</pubDate></item><item><title>Under-fives get swine flu jabs</title><link>http://traxfer.ft.com/cms/s/0/d4396ada-d574-11de-81ee-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/d4396ada-d574-11de-81ee-00144feabdc0.html</guid><description>Children under five will be the next group to be given priority in receiving the swine flu vaccine, Sir Liam Donaldson, the chief medical officer, said yesterday. The...</description><pubDate>Fri, 20 Nov 2009 02:00:00 +0000</pubDate></item><item><title>Regulations trim growth at United Drug</title><link>http://traxfer.ft.com/cms/s/0/84f26952-d427-11de-990c-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/84f26952-d427-11de-990c-00144feabdc0.html</guid><description>Reduced prices in its main Irish markets have crimped sales growth at the healthcare products supplier, in spite of strong growth in its contract sales and drug packaging businesses</description><pubDate>Thu, 19 Nov 2009 01:54:51 +0000</pubDate></item><item><title>Property concerns prompt NHS probe</title><link>http://traxfer.ft.com/cms/s/0/de0a4a46-d477-11de-a935-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/de0a4a46-d477-11de-a935-00144feabdc0.html</guid><description>An inquiry is being opened into how far the health service should retain control of its property when it puts services out to tender or allows mergers and takeovers</description><pubDate>Wed, 18 Nov 2009 23:15:33 +0000</pubDate></item><item><title>GSK deal draws smokers' vaccine closer</title><link>http://traxfer.ft.com/cms/s/0/f32e2cb4-d2fe-11de-af63-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/f32e2cb4-d2fe-11de-af63-00144feabdc0.html</guid><description>The NicVAX vaccine moved closer to the market after a deal between GlaxoSmithKline and the US biotech company Nabi Pharmaceuticals, which developed the product</description><pubDate>Mon, 16 Nov 2009 22:32:56 +0000</pubDate></item><item><title>GSK plans to cut drug production waste</title><link>http://traxfer.ft.com/cms/s/0/c2652114-d20e-11de-a0f0-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/c2652114-d20e-11de-a0f0-00144feabdc0.html</guid><description>The UK-based pharmaceutical group has set a target to cut by two-thirds the waste generated by medicines production </description><pubDate>Sun, 15 Nov 2009 22:23:34 +0000</pubDate></item><item><title>Grandma knows best when it comes to drugs</title><link>http://traxfer.ft.com/cms/s/0/3f89e3ac-d07d-11de-af9c-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/3f89e3ac-d07d-11de-af9c-00144feabdc0.html</guid><description>A small cluster of British drug companies is marketing drugs that are decades old, relying on consumers' affection for products that they probably first saw in their grandparents' medicine chest</description><pubDate>Sat, 14 Nov 2009 00:21:16 +0000</pubDate></item><item><title>Asian growth boosts sales at Synergy</title><link>http://traxfer.ft.com/cms/s/0/5b1ad192-cf80-11de-b876-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/5b1ad192-cf80-11de-b876-00144feabdc0.html</guid><description>Strong demand for the decontamination of hospital equipment in Asia and Europe has buoyed revenues at Synergy Healthcare, the health services company.</description><pubDate>Thu, 12 Nov 2009 15:33:23 +0000</pubDate></item><item><title>Ratiopharm offers emerge</title><link>http://traxfer.ft.com/cms/s/0/a4b21910-cf2a-11de-8a4b-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/a4b21910-cf2a-11de-8a4b-00144feabdc0.html</guid><description>Four financial investors, along with Israel's Teva, France's Sanofi-Aventis and the US's Pfizer, have submitted bids for the world's fourth-largest generic drugs group</description><pubDate>Thu, 12 Nov 2009 02:00:00 +0000</pubDate></item><item><title>Buy-out groups see off Apoteket's peers</title><link>http://traxfer.ft.com/cms/s/0/21454032-cd24-11de-a748-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/21454032-cd24-11de-a748-00144feabdc0.html</guid><description>Private equity groups triumphed over several industrial groups – including Alliance Boots – in the $858m auction of Sweden's state-owned pharmacy chain</description><pubDate>Mon, 9 Nov 2009 21:22:50 +0000</pubDate></item><item><title>    Sonova in $489m Advanced Bionics deal </title><link>http://traxfer.ft.com/cms/s/0/310b29a4-cd11-11de-a748-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/310b29a4-cd11-11de-a748-00144feabdc0.html</guid><description>The Swiss hearing aid manufacturer has made an agreed $489m cash offer for Advanced Bionics of the US, in a renewed push for global sales dominance  </description><pubDate>Mon, 9 Nov 2009 11:35:53 +0000</pubDate></item><item><title>IMS Health in $5.2bn leveraged buy-out</title><link>http://traxfer.ft.com/cms/s/0/711ffdfe-ca95-11de-97e0-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/711ffdfe-ca95-11de-97e0-00144feabdc0.html</guid><description>The prescription-drug data provider has agreed to sell itself to TPG Capital and Canada Pension Plan's investment board in what is the biggest such deal this year</description><pubDate>Fri, 6 Nov 2009 05:55:00 +0000</pubDate></item><item><title>Drug group acquisition boosts BTG</title><link>http://traxfer.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealth</link><guid>http://www.ft.com/cms/s/0/ae01c6a6-c9f2-11de-a5b5-00144feabdc0.html</guid><description>A full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next year</description><pubDate>Fri, 6 Nov 2009 05:14:54 +0000</pubDate></item></channel></rss>






    


